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ABSTRACT
Among metallic nanoparticles gold possess several unique properties. It has been argued that AuNPs have 
significant toxicity both in vitro and in vivo but that coating may partially prevent harmful effects. Chitosan is a 
natural polysaccharide derivative of chitin known to have immunoenhancing effects, antitumor, antifungal and 
antimicrobial activities. The aim of this study was to investigate the cytotoxic effect of chitosan-AuNPs on C26 
(murine colon carcinoma) and HeLa (human cervix carcinoma) cell lines. C26 and HeLa cells were exposed to 
10 and 60 nm sized chitosan-AuNPs at five different concentrations (5, 10, 25, 50 and 100 µg/ml). After 24 h of 
incubation, cytotoxicity was assessed by the MTT colorimetric method and IC50 values were calculated. In C26 
cells 60 nm particles were more toxic than 10 nm particles. On the other hand in HeLa cells the situation was 
reversed and 10 nm particles had the most harmful effect at a concentration 2.5 times smaller than that of 60 nm 
particles. Our results could suggest that chitosan-AuNPs have an antiproliferative effect on C26 and HeLa cell lines 
but that this depends on cell type and is influenced by particle size and concentration.
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INTRODUCTION
According to a recently suggested deﬁnition 
of the European Union nanotechnologies involve 
particles shorter than 100 nm at least in one 
dimension (BSI-PAS71, 2005). They are called 
‘intended’ particles because they are intentionally 
produced in order to fulfil speciﬁc functions or gain 
characteristics in science, technology, medicine, 
industries and many other applications (Kreyling 
et al., 2006; Pop et al., 2015).
Because of its chemical inertness, gold has 
been used internally in humans for the past 50 
years, from teeth to implants to radioactive gold 
used in cancer treatment (Mfhlen and Beller, 1979; 
Rosenberg et al., 1985).
The fact that amine (Selvakannan et al., 
2003) and thiol (Templeton et al., 2000) groups 
bind strongly to AuNPs has enabled their surface 
modification with amino acids (Selvakannan et 
al., 2004; Joshi et al., 2004), proteins (Phadtare 
et al., 2003) and DNA (Rosi et al., 2006). This 
has lead to important biomedical applications 
(reviwed by Shukla et al., 2005). Nanotechnology 
has broad applications in fighting cancer and can 
be employed in molecular imaging, molecular 
diagnosis, targeted therapy and bioinformatics 
(Cai et al., 2008).
 If clinical applications for NPs are to be 
developed their biocompatibility is crucial (Shukla 
et al., 2005) and further studies of their toxicity 
are required. It has been argued that naked 
AuNPs have significant toxicity both in vitro and 
in vivo, while appropriate coating with chitosan 
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or PEG may partially prevent their harmful effects 
(Jokerstet al., 2011; Sabella et al., 2011).
Chitosan is a natural polysaccharide derivative 
of chitin with biodegradable, biocompatible, 
non-toxic characteristics (Qi et al., 2005) and 
it is known to have immunoenhancing effects, 
antitumor, antifungal and antimicrobial activities 
(Roller and Covill, 1999; Wang et al., 2011; Zheng 
et al., 2003). Beside these, it can act as a stabilizing 
agent and can be used to tailor nanocomposite 
properties and also to provide long-term stability 
to the nanoparticles by preventing particle 
agglomeration (Chen et al., 2013). Bhumkar et al. 
(2007) developed a new strategy to exploit the use 
of chitosan as a reducing agent for the production 
of AuNPs. Interestingly, chitosan-AuNPs were 
bactericidal against antibiotic resistant strains 
of Staphylococcus aureus and Pseudomonas 
aeruginosa (Regiel-Futyra et al., 2015).
In vivo and in vitro studies regarding 
cytotoxicity of nanoparticles have contradictory 
results and there is still not enough information 
on their effects. In this context, we investigated the 
cytotoxic effect of chitosan-AuNPs on C26 (murine 
colon carcinoma) and HeLa (human cervical 
carcinoma) cell lines.
MATERIALS AND METHODS
Characterization of chitosan gold nanoparticles
Two solutions of chitosan-gold nanoparticles 
(chitosan-AuNPs) were graciously provided by the 
National Institute for Research and Development 
of Isotopic and Molecular Technologies Cluj-
Napoca. Nanoparticles were characterized by 
absorbance reading at 300-800 nm using a V-630 
UV-Vis Spectrophotometer in order to assess their size.
Cell lines and cell culture
Murine colon carcinoma cell line C26 (Cell 
Lines Service GmbH, Eppelheim, Germany) was 
maintained in RPMI-1640 medium without 
antibiotics but supplemented with 1 mM glutamine 
and 10% foetal bovine serum while for human 
tumour cervical HeLa (ATCC CCL-2) MEM medium 
supplemented with the same reagents was used.
MTT cell proliferation assay
Cytotoxicity was assessed using the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra- 
zolium bromide (MTT) colorimetric method. C26 
and HeLa cells were seeded at a concentration of 
1∙106/ ml into 96-well microplates and kept in 
their respective media for 24 hours. Afterwards, 
cells were exposed for 24 hours to media 
containing characterised chitosan-AuNPs from 
the two solutions at five different concentrations: 
5, 10, 25, 50 and 100 µg/ml using 5 wells for 
each concentration. Chitosan-Au NPs  had been 
sterilized by filtration through 0.22 µm pores. The 
media containing chitosan-AuNPs was eliminated 
and cells were washed with 150 µl phosphate 
buffered saline (PBS) which was then replaced 
with 150 µl MTT solution in PBS (0.5 mg/ml). The 
resulting formazan particles were solubilized 
with 200 µl dimethyl sulfoxide. The absorbance 
was read with the HT Synergy microplate plate 
reader (BioTek Instruments, USA) at 550 nm and 
expressed relative to the background absorbance 
read at 630 nm. Experiments were repeated 3 
times. Results were expressed as percentages 
of antiproliferative activity with respect to 
an untreated control and based on them IC50 
values were calculated using the Excel program 
(Microsoft Corporation, USA).
RESULTS AND DISCUSSIONS
Characterization of chitosan-AuNPs
Absorbance measurements indicated that 
particle diameter was 10 nm for the first solution 
while the second contained 60 nm sized particles.
Cell proliferation
We found that chitosan-AuNPs decreased 
cell proliferation in a dose dependent manner 
(Fig. 1). As shown by the IC50 values in C26 cells 
the antiproliferative effect was higher for 60 nm 
nanoparticles (25.70 µg/ml) than for 10 nm 
nanoparticles (36.70 µg/ml).
 The antiproliferative effect was higher in 
C26 cells than in HeLa cells for both types of 
chitosan-AuNPs. For HeLa cells the situation was 
different, with the 10 nm nanoparticles having a 
more powerful antiproliferative activity (IC50: 
43.36 µg/ml) than the 60 nm nanoparticles (IC50: 
107.43 µg/ml).
Cell morphology was visibly altered in 
both lines (Fig. 2). Characteristic changes such 
as vacuolation, cytoplasmic granulations and 
cell detachment were apparent after a 24 hour 
exposure and became worse as concentrationincreased.
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In vivo, Au-NPs sized 10-15 nm have been 
localised in all tissues including blood, liver, lung, 
spleen, kidney and heart of mice while particles 
between 200-250 nm showed very minute 
presence in organs including blood, brain and 
spleen (reviewed by Fratoddi et al, 2014). Stefan 
et al. (2013) have demonstrated that smaller sized 
chitosan-AuNPs (12 nm) show protective effects 
against toxicity induced by lipopolysaccharides in Wistar rats.
In vitro, cytotoxicity of AuNPs has been 
studied on various cell lines such as human skin 
fibroblasts (HeLa), human leukemia (K562), 
human hepatocarcinoma (HepG2), human breast 
carcinoma (SK-BR-3) (Fratoddi et al, 2014). 
Chitosan-AuNPs have been shown to induce 
cytotoxic effects on neural and non-neural 
cell types (Gao et al., 2012) but also to inhibit 
proliferation of human gastric carcinoma cell line 
MGC803 (Qi et al., 2005) while Choi et al. (2015) 
Fig. 1. Antiproliferative effect of chitosan-AuNPs in C26 cells (a) and HeLa cells (b)
a b
Fig. 2. Morphology of C26 cells treated with 60 nm chitosan-AuNPs (a, b) and HeLa cells 
treated with 10 nm chitosan-AuNPs (c,d).
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found that these appeared to provoke cell death in 
human lung carcinoma cells, line THP.
In the cell Au-NPs have been found free in 
the cytoplasm but also encased in a membrane-
bound vacuole, possibly an endosome or lysosome 
by Murdock (2010) and inside lysosomes and 
the reticuloendothelial network by Shukla et al. 
(2005). 
Mironava et al. (2010) found that differently 
sized AuNPs: 45 nm at a concentration of 20 μ g/
ml and 13 nm at 142 μ g/ml were sequestered 
inside large vacuoles without showing nuclei 
penetration. On the other hand Pan et al. (2007) 
reported that 1 and 4 nm gold nanoparticles were 
the most cytotoxic toward connective tissue mouse 
ﬁbroblasts (L929 mouse), cervical carcinoma 
epithelial cells (HeLa), mouse macrophages 
(J774A1) and melanoma cells (SK-Mel-28) (IC50 approximately 30-46 µg/ml), whereas 15 nm 
AuNPs were not toxic at concentrations up to 
100-fold higher (up to 6300 µg/ml). Conversely, 
Hondroulis et al. (2010) observed no diﬀerence 
in cytotoxicity of 10 and 100 nm AuNPs and 
Connor et al. (2005) found no cytotoxic eﬀects 
for 18 nm AuNPs up to a 100 μM concentration. 
AuNPs have been reported as being nontoxic 
and biocomapatible with mouse macrophages 
(RAW264.7 cell line) (Shukla et al., 2005). In 
contrast, 10 nm AuNPs coated with chitosan were 
found to be cytotoxic to human acute monocytic 
leukemia line THP-1 (Boyles et al., 2015). Chitosan 
coated AuNPs have been shown to promote 
bone formation (Choi et al., 2015) and proposed 
as carriers for insulin delivery (Bhumkar et al., 
2007). Our research shows that chitosan-AuNPs 
have an antiproliferative effect on C26 and HeLa 
cell lines. In murine colon carcinoma (C26) cells 
larger particles (60 nm) were more toxic than 
smaller ones (10 nm). On the other hand in human 
cervical carcinoma (HeLa) cells the situation was 
reversed and 10 nm particles did the most had 
the most detrimental effect at a concentration 2.5 
times smaller than that of 60 nm particles. 
CONCLUSION
Given the contradictory nature of results in 
the gold nanoparticle field and the recent use of 
chitosan-gold nanocomposites our aim was to 
investigate their cytotoxicity in murine colon carcinoma and human cervical carcinoma cells. 
Results of this research could suggest that the 
antiproliferative effect of chitosan-AuNPs depends 
on cell type and is influenced by particle size and concentration. 
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